180 Life Sciences Corp (ATNF)
2.47
-0.21
(-7.84%)
USD |
NASDAQ |
Nov 15, 12:38
180 Life Sciences Cash and Short Term Investments (Quarterly): 1.146M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.146M |
| March 31, 2024 | 0.676M |
| December 31, 2023 | 1.976M |
| September 30, 2023 | 2.662M |
| June 30, 2023 | 2.009M |
| March 31, 2023 | 2.646M |
| December 31, 2022 | 6.970M |
| September 30, 2022 | 3.589M |
| Date | Value |
|---|---|
| June 30, 2022 | 1.625M |
| March 31, 2022 | 5.669M |
| December 31, 2021 | 8.224M |
| September 30, 2021 | 11.69M |
| June 30, 2021 | 1.836M |
| March 31, 2021 | 6.053M |
| December 31, 2020 | 2.108M |
| December 31, 2019 | 0.0834M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.0834M
Minimum
Dec 2019
11.69M
Maximum
Sep 2021
3.685M
Average
2.377M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Seelos Therapeutics Inc | 0.294M |
| NovaBay Pharmaceuticals Inc | 0.776M |
| Palatin Technologies Inc | 9.527M |
| iBio Inc | 14.21M |
| Theriva Biologics Inc | 16.59M |